Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer
Nagel, R.
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
1980
ISSN/ISBN: 0070-4067 PMID: 7013324 Document Number: 156110
Document emailed within 1 workday
Related Documents
Chime-Udeh, E. 1991: Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2) Connecticut Medicine 55(9): 526-528Thongprasert, S.; Maoleekoonpairoj, S.; Laohavinij, S.; Thavichaigarn, P. 2000: Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study Journal of the Medical Association of Thailand 83(6): 676-680
Williams, C.J.; Barley, V.; Blackledge, G.; Hutcheon, A.; Kaye, S.; Smith, D.; Keen, C.; Webster, D.J.; Rowland, C.; Tyrrell, C. 1987: Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancer Cancer Treatment Reports 71(12): 1197-1201
Sarfaty, G.A.; Alder, S.J.; McLean, R.G. 1984: A pilot study of flutamide. a new agent in the treatment of advanced prostatic cancer Medical Journal of Australia 140(4): 219-221
Weissbach, L. 1992: Prospective randomized multicenter phase IIi study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate Der Urologe. Ausg. a 31(1): 62
Bouffioux, C. 1974: Histological study of prostatic cancer. Prognostic and therapeutic value Journal d'Urologie et de Nephrologie 80(12 Part 2): 531-540
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Adam, Z.; Coupková, H.; Kolek, V.; Kucera, M.; Loffelmann, L.; Martinez, A.; Nováková, M.; Průsa, P.; Reiterer, P.; Skalová, B. 1995: Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study Acta Medica Austriaca 22(5): 120-124
Giannakakis, T.; Kakolyris, S.; Theodoropoulos, E.; Kouroussis, C.; Michailakis, E.; Papadouris, S.; Tsitoura, M.; Kalbakis, K.; Souglakos, J.; Agelaki, S.; Vardakis, N.; Georgoulias, V. 2002: A multicenter phase Ii study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer Anticancer Research 22(6b): 3743-3748
Jiang, Z.F.; Xu, F.R.; Fan, J.; Li, B.J.; Gao, J.N.; Hu, J.W.; Wang, X.J.; Zhang, Y.Q.; Wang, J.H.; Li, F.; Liu, Q.; Liu, Y.H.; Wang, S.; Wang, Y.S.; Ouyang, Q.C.; Hu, B.; Sun, G.P.; Zhang, Y.; Zang, A.M.; Fan, P.Z.; Wu, C.P.; Liu, J.; Zhang, H.W.; Wang, W.; Hu, X.C.; Tang, L.L.; Zhang, J.; Bao, Y.Y.; Geng, C.Z.; Sun, Q.; Zhang, F.; Yin, Y.M.; Jiang, H.C.; An, Y.H. 2018: A multicenter, randomized, controlled, phase Ⅳ clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer Zhonghua Yi Xue Za Zhi 98(16): 1231-1235
Knönagel, H.; Bolle, J.F.; Hering, F.; Senn, E.; Hodel, T.; Neuenschwander, H.; Biedermann, C. 1989: Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study Helvetica Chirurgica Acta 56(3): 343-345
Iemwananonthachai, N.; Pattaranutaporn, P.; Chansilpa, Y.; Sukkasem, M. 2003: Hyperthermia in combination with radiation therapy for treatment of advanced inoperable breast cancer Journal of the Medical Association of Thailand 86(8): 715-721
Wechsel, H.W.; Zerbib, M.; Pagano, F.; Coptcoat, M.J. 1996: Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer European Urology 30(Suppl): 7
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
1978: Lung cancer: therapeutic guidelines for the surgeon. 2 out of 3 cases inoperable Münchener Medizinische Wochenschrift 720(17): 572
Grieco, A.; Lasorella, A.; Astone, A.; Vagliviello, L.; Bartoloni, C.; Barone, C. 1984: Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). a non-controlled study La Clinica Terapeutica 110(4): 353-358
Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Ohta, K.; Sawamura, A.; Miyahara, E.; Kim, R.; Toge, T. 2001: A case of inoperable advanced gall bladder cancer responding to intra-arterial infusion of 5-fluorouracil (5-FU) and leucovorin (LV) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(4): 516-519
Al-Saleh, K.; Abd El-Aziz, N.; Ali, A.; Abo Zeed, W.; Salah, T.; Elsamany, S.; Rasmy, A.; El Farargy, O.; Husain, S.; Al-Rikabi, A.; Alsaeed, E.; Aldiab, A.; Abd El-Warith, A. 2019: A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC) Gulf Journal of Oncology 1(30): 33-42
Maneechawakajorn, J.; Benjawongsathien, D. 2014: Prognostic role of thyroid transcription factor-1 (TTF-1) in advanced and inoperable adenocarcinoma subtype of lung cancer among Thai patients Journal of the Medical Association of Thailand 97(Suppl 11): S11-S17